KLASKIN CHRISTINE M 4
4 · AGENUS INC · Filed Jun 18, 2024
Insider Transaction Report
Form 4
AGENUS INCAGEN
KLASKIN CHRISTINE M
VP, Finance
Transactions
- Award
Stock Option
2024-06-11+3,125→ 3,125 totalExercise: $13.25Exp: 2034-01-26→ Common Stock (750 underlying) - Award
Stock Option
2024-06-11+10,642→ 10,642 totalExercise: $12.26Exp: 2034-01-16→ Common Stock (10,642 underlying) - Award
Stock Option
2024-06-11+6,250→ 6,250 totalExercise: $12.26Exp: 2034-01-16→ Common Stock (6,250 underlying)
Footnotes (3)
- [F1]Options were granted on January 16, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan. These options vest as to 50% of the underlying shares on June 27, 2024 and 50% of the underlying shares on September 27, 2024. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 212,840 Stock Options with an exercise price of $0.61.
- [F2]Options were granted on January 16, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 16, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 125,000 Stock Options with an exercise price of $0.61.
- [F3]Options were granted on January 26, 2024 subject to shareholder approval, which was obtained at the Company's annual shareholder meeting on June 11, 2024. Option awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan, and vests over three years with one-third of the award vesting on January 26, 2025 and the balance vesting in equal quarterly installments thereafter. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 62,500 Stock Options with an exercise price of $0.66.